ResearchImplementing a Disease-specific Multidisciplinary Team and Order Set for Hemophagocytic Lymphohistiocytosis in a Pediatric Hospital
ResearchPediatric Hemophagocytic Lymphohistiocytosis: Formation of an Interdisciplinary HLH Working Group at a Single Institution
ResearchEffect of Clarithromycin on Cytokines and Chemokines in Children with an Acute Exacerbation of Recurrent Wheezing: A Double-blind, Randomized, Placebo-controlled Trial
ResearchRespiratory Syncytial Virus–Induced Acute and Chronic Airway Disease is Independent of Genetic Background: An Experimental Murine Model
ResearchMicrobiologic and Immunologic Evaluation of a Single High Dose of Azithromycin for Treatment of Experimental Mycoplasma pneumoniae Pneumonia
ResearchEvaluation of LBM415 (NVP PDF-713), a Novel Peptide Deformylase Inhibitor, for Treatment of Experimental Mycoplasma pneumoniae Pneumonia
ResearchComparative Effects of Two Neutralizing Anti-Respiratory Syncytial Virus (RSV) Monoclonal Antibodies in the RSV Murine Model: Time versus Potency
ResearchImpact of Cethromycin (ABT-773) Therapy on Microbiological, Histologic, Immunologic, and Respiratory Indices in a Murine Model of Mycoplasma pneumoniae Lower Respiratory Infection
ResearchAnti-Respiratory Syncytial Virus (RSV) Neutralizing Antibody Decreases Lung Inflammation, Airway Obstruction, and Airway Hyperresponsiveness in a Murine RSV Model
ResearchRespiratory Syncytial Virus Induces Pneumonia, Cytokine Response, Airway Obstruction, and Chronic Inflammatory Infiltrates Associated with Long-term Airway Hyperresponsiveness in Mice
ResearchMycoplasma pneumoniae Induces Host-dependent Pulmonary Inflammation and Airway Obstruction in Mice
ResearchAsthma and Respiratory Syncytial Virus. New Opportunities for Therapeutic Intervention (Spanish)
ResearchAntimicrobial and Immunologic Activities of Clarithromycin in a Murine Model of Mycoplasma pneumoniae–Induced Pneumonia